Diego J. L. Lima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Diego J. L. Lima has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Vani Janaki Sabesan
Michigan State University, College of Human Medicine, East Lansing, MI, USA
9 shared publications - Howard Routman
Atlantis Orthopedics, Palm Beach Gardens, FL, USA
6 shared publications - Devin Q. John
Department of Orthopaedic Surgery, HCA Florida JFK Hospital, Atlantis, FL, USA
3 shared publications - James D. Whaley
Department of Orthopedic Surgery, Beaumont Health System, Royal Oak, MI, USA
3 shared publications Ravi T. Rudraraju
Levitetz Department of Orthopaedic Surgery Cleveland Clinic Florida, 2950 Cleveland Clinic Boulevard, Weston, Florida 33331, USA
3 shared publications- Ali Ahmed Mohamed
Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, USA
2 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Elsevier in Journal of Shoulder and Elbow Arthroplasty
Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty: A Retrospective Cohort Study
- 27 October 2026
- Published by Elsevier in Journal of Shoulder and Elbow Arthroplasty
Open AccessLiposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty: A Retrospective Cohort Study
- 11 August 2026
- Published by SAGE Publications in The American Journal of Sports Medicine
Arthroscopic Labral Repair Versus Debridement for Femoroacetabular Impingement: A Systematic Review and Meta-analysis of 2730 Hips
Background: Arthroscopic management of acetabular labral pathology in femoroacetabular impingement (FAI) has progressively shifted toward labrum preservation; however, the effectiveness of labral repair over debridement remains unsettled. Purpose: To compare arthroscopic labral repair versus debridement for FAI regarding patient-reported outcomes, pain, and risk of conversion to total hip arthroplasty (THA). Study Design: Systematic review and meta-analysis; Level of evidence, 3. Methods: The study protocol was registered on PROSPERO (CRD420251062063). A systematic search of PubMed, Embase, and the Cochrane Central Register of Controlled Trials was performed through October 21, 2025. Randomized controlled trials (RCTs) and comparative cohort studies evaluating arthroscopic labral repair versus arthroscopic labral debridement for FAI were included. Open procedures and labral reconstruction were excluded to minimize clinical heterogeneity. Outcomes included the Modified Harris Hip Score (mHHS), Hip Outcome Score–Activities of Daily Living (HOS-ADL), Hip Outcome Score–Sport-Specific Subscale (HOS-SSS), visual analog scale (VAS) pain score, and conversion to THA. Random-effects models were applied, with prespecified subgroup analyses by study design and follow-up duration (P = .006), driven by long-term follow-up. Conclusion: Labral repair confers a significant protective benefit against conversion to THA and superior pain relief at mid- to long-term follow-up. While functional outcomes appear equivalent in observational cohorts, randomized evidence demonstrates superior activity-related scores favoring repair.
- 11 August 2026
- Published by SAGE Publications in The American Journal of Sports Medicine
Arthroscopic Labral Repair Versus Debridement for Femoroacetabular Impingement: A Systematic Review and Meta-analysis of 2730 Hips
Background: Arthroscopic management of acetabular labral pathology in femoroacetabular impingement (FAI) has progressively shifted toward labrum preservation; however, the effectiveness of labral repair over debridement remains unsettled. Purpose: To compare arthroscopic labral repair versus debridement for FAI regarding patient-reported outcomes, pain, and risk of conversion to total hip arthroplasty (THA). Study Design: Systematic review and meta-analysis; Level of evidence, 3. Methods: The study protocol was registered on PROSPERO (CRD420251062063). A systematic search of PubMed, Embase, and the Cochrane Central Register of Controlled Trials was performed through October 21, 2025. Randomized controlled trials (RCTs) and comparative cohort studies evaluating arthroscopic labral repair versus arthroscopic labral debridement for FAI were included. Open procedures and labral reconstruction were excluded to minimize clinical heterogeneity. Outcomes included the Modified Harris Hip Score (mHHS), Hip Outcome Score–Activities of Daily Living (HOS-ADL), Hip Outcome Score–Sport-Specific Subscale (HOS-SSS), visual analog scale (VAS) pain score, and conversion to THA. Random-effects models were applied, with prespecified subgroup analyses by study design and follow-up duration (P = .006), driven by long-term follow-up. Conclusion: Labral repair confers a significant protective benefit against conversion to THA and superior pain relief at mid- to long-term follow-up. While functional outcomes appear equivalent in observational cohorts, randomized evidence demonstrates superior activity-related scores favoring repair.
- Open Access
- 1 May 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 6 (3) , 100767
Prognostic value of the Neer and Mayo-Fundacion Jimenez Diaz classifications in reverse shoulder arthroplasty for proximal humerus fractures
- 1 May 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 6 (3) , 100767
Open AccessPrognostic value of the Neer and Mayo-Fundacion Jimenez Diaz classifications in reverse shoulder arthroplasty for proximal humerus fractures
- Open Access
- 29 March 2026
- Published by Charter Services New York d/b/a Journal of Orthopaedic Experience and Innovation in Journal of Orthopaedic Experience & Innovation
- Vol. 7 (1)
Quadriceps Tendon Versus Bone-Patellar Tendon-Bone Autograft for ACL Reconstruction in Athletes: A Systematic Review and Meta-Analysis
Background: Quadriceps tendon (QT) and bone–patellar tendon–bone (BPTB) autografts are common options for anterior cruciate ligament reconstruction (ACLR). While outcomes in mixed populations are generally comparable, few reviews have specifically examined competitive athletes, who face higher functional demands and reinjury risk. Hypothesis/Purpose: We hypothesized that clinical outcomes would differ between QT and BPTB autografts in athletes undergoing ACLR. The purpose was to compare graft failure, return to sport, and functional outcomes between these graft choices. Study Design: Systematic review and meta-analysis. Methods: A systematic search of PubMed, EMBASE, Web of Science, and Cochrane Library was performed through March 2025. Eligible studies included randomized controlled trials or cohort studies of competitive athletes undergoing primary ACLR with QT or BPTB autografts, reporting graft failure, return to sport, Lysholm score, or IKDC score. Studies involving pediatric patients, multiligament injuries, non-athletic populations, or other grafts were excluded. Data were pooled using random-effects meta-analysis, and certainty of evidence was assessed. Results: Three studies comprising 165 athletes met inclusion criteria. Pooled analysis showed no significant difference in graft failure between QT and BPTB (OR 3.69; 95% CI, 0.60–22.59; p = 0.16; I² = 0%). Return to sport rates were similar (OR 0.90; 95% CI, 0.37–2.20; p = 0.81). Functional outcomes were also comparable: Lysholm score (MD –0.62; 95% CI, –3.49 to 2.24; p = 0.67) and IKDC score (MD –1.63; 95% CI, –4.33 to 1.08; p = 0.24). None of the included studies reported outcomes for QT soft-tissue versus bone-block subtypes, preventing subgroup analysis. Certainty of evidence was rated low due to risk of bias and imprecision. Conclusion: QT and BPTB autografts demonstrate comparable rates of graft failure, return to sport, and functional scores in athletes undergoing ACLR. QT may be considered a viable alternative to BPTB in high-demand populations. Clinical Relevance: Given comparable outcomes, QT autografts represent a reasonable option for athletes, particularly when minimizing anterior knee morbidity associated with BPTB graft harvest is desirable.
- 29 March 2026
- Published by Charter Services New York d/b/a Journal of Orthopaedic Experience and Innovation in Journal of Orthopaedic Experience & Innovation
- Vol. 7 (1)
Open AccessQuadriceps Tendon Versus Bone-Patellar Tendon-Bone Autograft for ACL Reconstruction in Athletes: A Systematic Review and Meta-Analysis
Background: Quadriceps tendon (QT) and bone–patellar tendon–bone (BPTB) autografts are common options for anterior cruciate ligament reconstruction (ACLR). While outcomes in mixed populations are generally comparable, few reviews have specifically examined competitive athletes, who face higher functional demands and reinjury risk. Hypothesis/Purpose: We hypothesized that clinical outcomes would differ between QT and BPTB autografts in athletes undergoing ACLR. The purpose was to compare graft failure, return to sport, and functional outcomes between these graft choices. Study Design: Systematic review and meta-analysis. Methods: A systematic search of PubMed, EMBASE, Web of Science, and Cochrane Library was performed through March 2025. Eligible studies included randomized controlled trials or cohort studies of competitive athletes undergoing primary ACLR with QT or BPTB autografts, reporting graft failure, return to sport, Lysholm score, or IKDC score. Studies involving pediatric patients, multiligament injuries, non-athletic populations, or other grafts were excluded. Data were pooled using random-effects meta-analysis, and certainty of evidence was assessed. Results: Three studies comprising 165 athletes met inclusion criteria. Pooled analysis showed no significant difference in graft failure between QT and BPTB (OR 3.69; 95% CI, 0.60–22.59; p = 0.16; I² = 0%). Return to sport rates were similar (OR 0.90; 95% CI, 0.37–2.20; p = 0.81). Functional outcomes were also comparable: Lysholm score (MD –0.62; 95% CI, –3.49 to 2.24; p = 0.67) and IKDC score (MD –1.63; 95% CI, –4.33 to 1.08; p = 0.24). None of the included studies reported outcomes for QT soft-tissue versus bone-block subtypes, preventing subgroup analysis. Certainty of evidence was rated low due to risk of bias and imprecision. Conclusion: QT and BPTB autografts demonstrate comparable rates of graft failure, return to sport, and functional scores in athletes undergoing ACLR. QT may be considered a viable alternative to BPTB in high-demand populations. Clinical Relevance: Given comparable outcomes, QT autografts represent a reasonable option for athletes, particularly when minimizing anterior knee morbidity associated with BPTB graft harvest is desirable.
- 5 March 2026
- Published by SAGE Publications in HIP International
- Vol. 36 (5) , 713-722
Direct superior approach versus posterior approach in patients with primary total hip arthroplasty: a systematic review and meta-analysis
Objectives: The benefits and risks of the minimally invasive direct superior approach (DSA) compared with the posterior approach (PA) in primary total hip arthroplasty (THA) remain uncertain. Methods: We performed a systematic review and meta-analysis comparing DSA and PA in primary THA. Outcomes included perioperative parameters, radiological and functional results, and postoperative complications. Statistical analysis was performed using Review Manager, with heterogeneity assessed using I 2 . Subgroup analyses were restricted to randomised controlled trials (RCTs). Results: 11 studies comprising 5217 patients were included, with 1259 undergoing DSA. DSA was associated with a shorter hospital stay (MD −0.67 days; p < 0.00001), reduced blood loss (MD −66.09 mL; p = 0.007), and increased Harris Hip Scores (HHS) within 3 months (MD 1.00; p = 0.03). No significant differences were observed in operating time, radiological outcomes, Oxford Hip Score, Western Ontario and McMaster Universities Osteoarthritis Score, 12-month HHS, or postoperative complications. Subgroup analysis revealed differences between RCTs and observational studies in length of stay ( p < 0.0004), leg-length discrepancy ( p = 0.07), and operating time ( p = 0.04). Conclusions: DSA appears to be a safe, effective alternative to PA, providing less blood loss, shorter hospitalisation, and faster early recovery without compromising mid-term outcomes.
- 5 March 2026
- Published by SAGE Publications in HIP International
- Vol. 36 (5) , 713-722
Direct superior approach versus posterior approach in patients with primary total hip arthroplasty: a systematic review and meta-analysis
Objectives: The benefits and risks of the minimally invasive direct superior approach (DSA) compared with the posterior approach (PA) in primary total hip arthroplasty (THA) remain uncertain. Methods: We performed a systematic review and meta-analysis comparing DSA and PA in primary THA. Outcomes included perioperative parameters, radiological and functional results, and postoperative complications. Statistical analysis was performed using Review Manager, with heterogeneity assessed using I 2 . Subgroup analyses were restricted to randomised controlled trials (RCTs). Results: 11 studies comprising 5217 patients were included, with 1259 undergoing DSA. DSA was associated with a shorter hospital stay (MD −0.67 days; p < 0.00001), reduced blood loss (MD −66.09 mL; p = 0.007), and increased Harris Hip Scores (HHS) within 3 months (MD 1.00; p = 0.03). No significant differences were observed in operating time, radiological outcomes, Oxford Hip Score, Western Ontario and McMaster Universities Osteoarthritis Score, 12-month HHS, or postoperative complications. Subgroup analysis revealed differences between RCTs and observational studies in length of stay ( p < 0.0004), leg-length discrepancy ( p = 0.07), and operating time ( p = 0.04). Conclusions: DSA appears to be a safe, effective alternative to PA, providing less blood loss, shorter hospitalisation, and faster early recovery without compromising mid-term outcomes.
- 18 February 2026
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 36 (2)
A cost-utility analysis of pre-operative 12-week smoking cessation program in adults with indications of undergoing elective shoulder arthroplasty
- 18 February 2026
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 36 (2)
A cost-utility analysis of pre-operative 12-week smoking cessation program in adults with indications of undergoing elective shoulder arthroplasty
- 4 September 2025
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 35 (4) , 685-691
Determining the minimal clinically important difference and substantial clinical benefit following revision reverse shoulder arthroplasty
- 4 September 2025
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 35 (4) , 685-691
Determining the minimal clinically important difference and substantial clinical benefit following revision reverse shoulder arthroplasty
- 29 August 2025
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 35 (4) , 662-668
Rate of improvement following reverse shoulder arthroplasty: a comparison of primary and revision reverse shoulder arthroplasty
- 29 August 2025
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 35 (4) , 662-668
Rate of improvement following reverse shoulder arthroplasty: a comparison of primary and revision reverse shoulder arthroplasty
- 28 November 2022
- Published by Elsevier in The Journal of Foot and Ankle Surgery
- Vol. 62 (4) , 605-609
The Impact of Hospital Size and Teaching Status on Outcomes Following Total Ankle Arthroplasty
- 28 November 2022
- Published by Elsevier in The Journal of Foot and Ankle Surgery
- Vol. 62 (4) , 605-609
The Impact of Hospital Size and Teaching Status on Outcomes Following Total Ankle Arthroplasty